FDA Inspection
Shouguang Fukang Pharmaceutical Co., Ltd.Shouguang Fukang Pharmaceutical Co., Ltd. – FDA Inspection, Feb 21, 2025
Record Details
This FDA Inspection record concerns Shouguang Fukang Pharmaceutical Co., Ltd., with an inspection on February 21, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- February 21, 2025
- Product Type
- Human Drugs
View Company Profile
ID · 96bbd8ce-db68-4feb-a8a6-1c39f28cbf38
Inspection Facts
- Inspection number
- 1265107
- FDA center
- Human Drugs
Other FDA inspections of Shouguang Fukang Pharmaceutical Co., Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 25, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 16, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 6, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 31, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shouguang Fukang Pharmaceutical Co., Ltd.
- FDA Inspection 1054215 - 2018-05-25
- FDA Inspection 989215 - 2016-09-16
- FDA Inspection 884937 - 2014-06-06
- FDA Inspection 722603 - 2011-03-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.